Neumora Therapeutics, Inc.

By person

16 insiders · 76 transactions

16.8×

Paul L. Berns holds 16.8 times base salary in stock. $11.80M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul L. Berns last reported holding, valued at $1.60, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ARCH Venture Partners X, LLC entity

10% owner

$56.00M (3)

—

+$56.00M

6,046,907

3.22%

$9.65M

—

Burow Kristina

Director

$36.43M (20)

—

+$36.43M

6,094,624

3.24%

$9.73M

—

AMGEN INC entity

10% owner

$30.00M (1)

—

+$30.00M

35,368,653

18.82%

$56.44M

—

ARCH Venture Partners XII, LLC entity

10% owner

$10.93M (19)

—

+$10.93M

6,046,907

3.22%

$9.65M

+246.6%

Pinto Joshua

President & CEO

—

$1.20M (6) scheduled

−$1.20M

209,950

0.1117%

$335.04K

−56.1%

Lenz Robert A.

Head of R&D

—

$1.09M (6) scheduled

−$1.09M

309,092

0.1645%

$493.25K

—

Aurora Daljit Singh

See Remarks

—

$1.04M (14) scheduled

−$1.04M

48,750

0.0259%

$77.80K

−78.7%

Fust Matthew K

Director

—

$370.96K (2) scheduled

−$370.96K

20,100

0.0107%

$32.08K

—

Gosebruch Henry O

President & CEO

$189.37K (1)

—

+$189.37K

477,345

0.2540%

$761.75K

+24.8%

BERNS PAUL L

See Remarks

—

$57.93K (2)

−$57.93K

7,395,185

3.94%

$11.80M

−3.3%

Milligan Michael Lee

See Remarks

—

$8.47K (2) scheduled

−$8.47K

21,034

0.0112%

$33.57K

+450.2%

Suh Carol Y.

Chief Operating Officer

—

374,674

0.1994%

$597.90K

+29.3%

FMR LLC entity

See Remark 1

—

88,289

0.0470%

$140.89K

—

Ho Maykin

Director

—

20,100

0.0107%

$32.08K

—

Piacquad David

Director

—

20,100

0.0107%

$32.08K

—

Halawa Alaa

Director

—

20,100

0.0107%

$32.08K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Aurora Daljit Singh

21 Aug 2026

See Remarks

Sold after exercise indirect

21,055

$1.60

$33.60K

Aurora Daljit Singh

21 Aug 2026

See Remarks

Sold after exercise

20,553

$1.59

$32.78K

Aurora Daljit Singh

20 Aug 2026

See Remarks

Sold after exercise indirect

66,711

$1.51

$101.00K

Aurora Daljit Singh

20 Aug 2026

See Remarks

Sold after exercise

67,741

$1.51

$102.59K

Aurora Daljit Singh

19 Aug 2026

See Remarks

Sold after exercise indirect

30,918

$1.65

$50.89K

Aurora Daljit Singh

19 Aug 2026

See Remarks

Sold after exercise

31,000

$1.65

$51.03K

Aurora Daljit Singh

18 Aug 2026

See Remarks

Sold after exercise indirect

34,987

$1.59

$55.49K

Aurora Daljit Singh

18 Aug 2026

See Remarks

Sold after exercise

34,162

$1.58

$54.14K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise indirect

55,016

$1.50

$82.78K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise

34,020

$1.49

$50.53K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise

57,670

$1.51

$86.82K

Fust Matthew K

18 Oct 2024

Director

Sold after exercise

14,049

$17.03

$239.32K

Fust Matthew K

17 Oct 2024

Director

Sold after exercise

7,739

$17.01

$131.64K

Show all 76 transactions →

Neumora Therapeutics, Inc.

By person

Individual transactions

What was left out